Literature DB >> 12771439

Haemophagocytic syndrome in a rheumatoid arthritis patient treated with infliximab.

A Aouba, M De Bandt, E Aslangul, N Atkhen, B Patri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12771439     DOI： 10.1093/rheumatology/keg187

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

2.  Haemophagocytic syndrome and paradoxical reaction to tuberculostatics after treatment with infliximab.

Authors:  Amelia Troncoso Mariño; Eva Campelo Sánchez; Noemí Martínez López de Castro; María Teresa Inaraja Bobo
Journal:  Pharm World Sci       Date:  2010-02-02

3.  Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature.

Authors:  Guido Granata; Dario Didona; Giuseppina Stifano; Aldo Feola; Massimo Granata
Journal:  Case Rep Med       Date:  2015-05-07

4.  High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome.

Authors:  Karin Palmblad; Hanna Schierbeck; Erik Sundberg; Anna-Carin Horne; Helena Erlandsson Harris; Jan-Inge Henter; Daniel J Antoine; Ulf Andersson
Journal:  Mol Med       Date:  2015-01-27       Impact factor: 6.354
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.